Zafgen
Boston, Massachusetts, USA
Team Members:
Peter Barrett
Bruce Booth
Sector:
Life Sciences
Sub-Sector:
Therapeutics
Close
Zafgen is a new biopharmaceutical company focused on developing a novel obesity therapy based on the vascular targeting of adipose tissue.
In the News:
Zafgen, Inc. Named One of the “Fierce 15” Leading Biotech Companies of 2009
Zafgen, Inc. Appoints Matthias Jaffe to Chief Financial Officer and Vice President of Business Development
Zafgen, Inc. Appoints Matthias Jaffe to Chief Financial Officer and Vice President of Business Development
Argenta Discovery and Zafgen Announce Contract Drug Discovery Collaboration in Obesity
Zafgen Shrinks Fat by Inhibiting Angiogenesis in Adipose Cells
Zafgen Inc. Appoints Industry Veteran and Recognized Metabolic Disorders Expert Thomas Hughes, Ph.D., as Company's First Chief Executive Officer
Anthill Technologies Announces Agreement with Zafgen
